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Abstract 
Background: Rhizoma Chuanxiong (RC; Chuanxiong), which is the dried rhizome of Ligusticum chuanxiong (Umbel‑
liferae), is commonly used in Chinese medicine (CM) for improving blood circulation and dispersing blood stasis. RC 
is usually processed before use in clinical practice to enhance its therapeutic efficacy. This study aimed to investigate 
the temporal variations of the major constituents of RC by HPLC‑DAD‑MS during herbal processing to investigate the 
effects of an adjuvant (e.g., wine), steaming vs stir‑frying and the optimal processing time.
Methods: An HPLC‑DAD‑MS method was developed to determine the major constituents of the RC processed by 
one of the four processing methods, i.e., stir‑frying, steaming, stir‑frying with rice wine and steaming with rice wine. 
Processing was conducted over 60 min. Six major compounds, namely ferulic acid, senkyunolide I, senkyunolide H, 
senkyunolide A, Z‑ligustilide and levistolide A, were selected as markers to analyze the effects on the markers’ levels of 
the different processing methods and optimize the processing time.
Results: The results indicated that (a) processing with wine had no discernible impact on the amounts of the six 
chemical markers in RC; (b) the amounts of the major constituents of RC subjected to steam processing were higher 
than those of the RC subjected to stir‑fry processing.
Conclusion: Among the four different methods evaluated for RC processing, steaming was better and the optimal 
time for steaming RC was 40 min.
© 2016 Yi et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Herbs can be processed in a variety of different ways, 
including parching, stir-baking with liquid, calcination, 
roasting in fresh cinders, steaming and boiling. Certain 
processing methods can affect the properties and func-
tions of herbs by reducing their side effects and enhanc-
ing their biological efficacy, and can therefore be used 
to facilitate herbal decoction preparation and preser-
vation. Raw Chinese medicinal herbs and teas are sub-
jected to extensive processing procedures prior to being 
used in clinical prescriptions or for the preparation of 
proprietary Chinese medicines [1, 2]. Assessing the 
effects of various processing methods and optimizing the 
processing parameters are important to Chinese medi-
cine (CM) for producing the most effective herbs from 
raw herbal materials.
Rhizoma Chuanxiong (RC; Chuanxiong), which is the 
dried rhizome of Ligusticum chuanxiong Hort (Umbellif-
erae), is used in CM for the treatment of cerebrovascular 
and cardiovascular diseases, including stroke, hyper-
tension and arrhythmia, as well as several endocrine 
disorders [3–7]. A wide range of compounds of RC has 
been isolated and identified in previous studies; most 
of which were determined to contain lactones, such as 
alkylphthalides and phthalide dimmers [8–12]. Ferulic 
acid (1) exhibits a number of interesting biological func-
tions, such as reducing the level of nitrite and oxygen 
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free radicals, lowering blood lipids, resisting bacteria and 
reducing inflammation [13]. Ferulic acid (1) is also used 
as a biomarker for RC in the Chinese Pharmacopoeia [3]. 
The lactones found in RC can pass through the blood 
brain barrier and could therefore be the active ingredi-
ents in RC [14]. Senkyunolide I (2) can be used to treat 
migraine [15], whereas senkyunolide H (3) can be used 
to reduce the metamorphose damage of red blood cells 
(RBC), as well as preventing the aggregation of RBC [16]. 
Senkyunolide A (4) can be used to treat inflammatory 
processes associated with cerebrovascular diseases [7]. 
High levels of Z-ligustilide (5) can be extremely irritating 
to the human body and prevent other constituents from 
achieving their biological efficacies [17, 18]. In addition, 
levistolide A (6) is a dimer of Z-ligustilide (5), and there-
fore directly related to the Z-ligustilide (5) content [19].
RC is processed in rice wine prior to being used in clin-
ical applications to enhance its blood circulation prop-
erties [20]. RC is generally prepared by stir-frying with 
rice wine [21]. However, several steamed products are 
also used in clinical practice [22]. The optimum process-
ing conditions and processing methods should always be 
explored in detail to ensure that the raw materials reach 
their maximum efficacy. However, the studies pertain-
ing to the effects of different processing methods on the 
medicinal properties of RC are scarce, with the majority 
of these studies focusing specifically on the effects of the 
processing time [23–25]. It was reported that there are 
post-harvest variations in the main chemical ingredients 
of fresh, dried and processed Ligusticum chuanxiong [26], 
but the study compared only the constituents in the final 
products after processing and there have been no reports 
pertaining to temporal variations in the constituents 
during processing. Furthermore, the optimal processing 
time remains unknown. Processing is dynamic; thus, we 
should monitor the changes to determine the optimal 
parameters for processing.
Although a wide variety of different chemical con-
stituents are present in RC, ferulic acid, senkyunolide I, 
senkyunolide H, senkyunolide A, Z-ligustilide and levis-
tolide A are the components commonly used as chemi-
cal markers [27] (Fig. 1). This study aimed to investigate 
the temporal variations of the major constituents of RC 
by HPLC-DAD-MS during processing to investigate the 
effects of an adjuvant (e.g., wine), steaming vs stir-frying 
and the optimal processing time.
Methods
Plant materials
The RC, which was produced in Sichuan, was purchased 
from Qingping Market in Guangzhou, China in 2013. 
The herbs were authenticated based on their morpho-
logical characteristics [4] by Dr. Yi Tao at the School of 
Chinese Medicine, Hong Kong Baptist University, China. 
The cleaned RC samples were initially graded according 
to their sizes, before being macerated in water until they 
were wet to the core. The RC was then removed from the 
water and cut into thin slices, before being air-dried at 
room temperature. The resulting dried pieces of RC con-
sisted of irregular slices of 1–2  mm in thickness, which 
were divided into four groups. The processing methods 
and quantities of materials produced in this way are 
described below in the “Preparation of processed RC” 
section.
Reagents and chemicals
Rice wine (Zhejiang Pagoda Band Shaoxing Rice Wine 




Ferulic acid (1) Senkyunolide I (2) Senkyunolide H (3)
Senkyunolide A (4) Z-Ligustilide (5) Levistolide A (6)
Fig. 1 Structures of the six major compounds found in Rhizoma Chuanxiong
Page 3 of 8Yi et al. Chin Med  (2016) 11:26 
supermarket in Hong Kong, China. Ferulic acid (1) was 
purchased from the National Institute for the Control of 
Pharmaceutical and Biological Products (Beijing, China). 
The chemical standards of senkyunolide I (2), senkyu-
nolide H (3), senkyunolide A (4), Z-ligustilide (5) and 
levistolide A (6) used in the current study were isolated 
from RC in our laboratory [11].
Acetonitrile and formic acid were purchased in liquid 
chromatography grade from Lab-scan (Bangkok, Thai-
land). The methanol used for the extraction of the sam-
ples was also purchased from Lab-scan. Deionized water 
was generated using a Milli-Q water purification system 
(Millipore, Bedford, MA, USA).
Preparation of processed RC
Four different RC processing methods were employed in 
the current study. Each processing method was designed 
according to standard protocols [21]. These four differ-
ent methods were: (1) stir-frying only, in which the dried 
RC slices were stir-fried alone in a pan at a temperature 
of 200 °C to avoid scorching; (2) steaming only, in which 
the dried RC slices were steamed alone in a steamer; (3) 
stir-frying with rice wine, in which the dried RC slices 
(50 g) were soaked in 5 mL of rice wine before frying at 
100  °C; and (4) steaming with rice wine, in which the 
dried RC slices (50 g) were soaked in 5 mL of rice wine 
before steaming in a steamer. Samples were withdrawn 
from each process at 5, 10, 15, 20, 25, 30, 35, 40, 50, 55 
and 60  min during processing. Sample duplicates were 
prepared as shown above for analysis.
HPLC‑DAD‑MS instrumentation and conditions
An Agilent 1100 high-performance liquid chromatogra-
phy (HPLC) system equipped with a diode array detector 
(DAD) and a quadrupole time-of-flight mass spectrom-
etry (TOF–MS) system was used for the qualitative and 
quantitative analysis of the different samples. The sam-
ples were analyzed over an Alltima C18 column (5  µm, 
4.6  ×  250  mm). Standard solutions of the six chemical 
standards and RC sample solutions derived from the four 
different processing methods were prepared and ana-
lyzed according to previously reported procedures [11].
Results and discussion
Identification of the major components of RC
The standard solutions and sample solutions were 
injected into the HPLC-DAD-MS system described above 
for analysis. By comparing with standard compounds, six 
major peaks in the chromatograms of RC were unam-
biguously identified as ferulic acid (1), senkyunolide I (2), 
senkyunolide H (3), senkyunolide A (4), Z-ligustilide (5) 
and levistolide A (6). A typical HPLC chromatogram of 
RC recorded at 280 nm is shown in Fig. 2 together with a 
total ion chromatogram (TIC) of this material in the pos-
itive ionization mode. The MS spectra of the six different 
components are shown in Figs. 3 and 4.  
Fig. 2 Typical a HPLC chromatogram of processed Rhizoma Chuanxiong at 280 nm and b TIC chromatogram of this material in the positive ioniza‑
tion mode
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Effect of the processing method on the major constituents
The RC samples collected from the different processing 
methods at different time points were analyzed using 
the present method (Fig. 5). Pronounced variations were 
observed in the ferulic acid (1), senkyunolide I (2), senk-
yunolide H (3), senkyunolide A (4), Z-ligustilide (5) and 
levistolide A (6) contents of the RC samples processed 















Fig. 3 The MS spectra of a ferulic acid, b senkyunolide I, c senkyunolide H
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(1) content of the samples derived from the four different 
processing methods initially increased significantly until 
it reached a plateau and remained stable with increasing 
processing time. The senkyunolide I (2), senkyunolide 
H (3) and senkyunolide A (4) contents of the samples 
derived from the four different processing methods also 
increased slightly with increasing processing time. In 












Fig. 4 The MS spectra of a senkyunolide A, b Z‑ligustilide and c levistolide A in the positive ionization mode
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time in all four cases. Lastly, the levistolide A (6) content 
remained unchanged for the four different processing 
methods. In general, the amounts of the major constitu-
ents were higher after steaming than after stir-frying.
Optimization of the processing time
In this study, we considered ferulic acid (1), senkyu-
nolide I (2), senkyunolide H (3) and senkyunolide A 
(4) as active ingredients, whereas Z-ligustilide (5) and 
levistolide A (6) were considered to be adverse ingredi-
ents. The ratios of the active and adverse ingredients to 
the six major compounds during the steam processing 
of RC are clearly shown in Fig. 6. These data were used 
to determine the optimal processing time of the steam-
processing method. Steaming in the absence of an 
adjuvant, which led to an increase in the ratio of active 
ingredients as well as a decrease in the ratio of adverse 
ingredients, was found more suitable for the processing 
of RC than steaming with rice wine. The curves shown in 
Fig. 6a initially increased with increasing processing time 
before reaching a plateau. In contrast, the curves shown 
in Fig.  6b initially decreased before reaching a plateau. 
These transitions were observed in a single experiment 







































































































Fig. 5 Changes in the a ferulic acid, b senkyunolide I, c senkyunolide H, d senkyunolide A, e Z‑ligustilide and f levistolide A contents of the Rhi‑
zoma Chuanxiong samples subjected to the four different processing methods over time (n = 3)
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Conclusion
Among the four different methods evaluated for RC pro-
cessing, steaming was better than stir-frying for preserv-
ing high amounts of beneficial chemical markers and 
affording low amounts of adverse ingredients.
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Fig. 6 The content ratios of a (ferulic acid + senkyunolide I + senkyunolide H + senkyunolide A)/six major compounds; b (Z‑ligustilide + levis‑
tolide A)/six major compounds at different time points for steam‑processed Rhizoma Chuanxiong (n = 3)
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